Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Topical Versus Intravenous Tranexamic Acid in Patients Undergoing Cardiac Surgery: The DEPOSITION Randomized Controlled Trial

A. Lamy, DA. Sirota, F. Jacques, A. Poostizadeh, N. Noiseux, S. Efremov, P. Demers, B. Akselrod, CY. Wang, RC. Arora, P. Branny, SP. McGuinness, CD. Brown, H. Jeanmart, Q. Zhao, H. Zhang, EP. Belley-Côté, RP. Whitlock, A. Browne, I. Copland, J....

. 2024 ; 150 (17) : 1315-1323. [pub] 20240408

Language English Country United States

Document type Journal Article, Randomized Controlled Trial, Multicenter Study, Comparative Study

BACKGROUND: Although intravenous tranexamic acid is used in cardiac surgery to reduce bleeding and transfusion, topical tranexamic acid results in lower plasma concentrations compared with intravenous tranexamic acid, which may lower the risk of seizures. We aimed to determine whether topical tranexamic acid reduces the risk of in-hospital seizure without increasing the risk of transfusion among cardiac surgery patients. METHODS: We conducted a multicenter, double dummy, blinded, randomized controlled trial of patients recruited by convenience sampling in academic hospitals undergoing cardiac surgery with cardiopulmonary bypass. Between September 17, 2019, and November 28, 2023, a total of 3242 patients from 16 hospitals in 6 countries were randomly assigned (1:1 ratio) to receive either intravenous tranexamic acid (control) through surgery or topical tranexamic acid (treatment) at the end of surgery. The primary outcome was seizure, and the secondary outcome was red blood cell transfusion. After the last planned interim analysis, when 75% of anticipated participants had completed follow up, the data and safety monitoring board recommended to terminate the trial, and upon unblinding, the operations committee stopped the trial for safety. RESULTS: Among 3242 randomized patients (mean age, 66.0 years; 77.7% male), in-hospital seizure occurred in 4 of 1624 patients (0.2%) in the topical group, and 11 of 1628 patients (0.7%) in the intravenous group (absolute risk difference, -0.5% [95% CI, -0.9 to 0.03]; P=0.07). Red blood cell transfusion occurred in 570 patients (35.1%) in the topical group and in 433 (26.8%) in the intravenous group (absolute risk difference, 8.3% [95% CI, 5.2-11.5]; P=0.007). The absolute risk difference in transfusion of ≥4 units of red blood cells in the topical group compared with the intravenous group was 8.2% (95% CI, 3.4-12.9). CONCLUSIONS: Among patients undergoing cardiac surgery, topical administration of tranexamic acid resulted in an 8.3% absolute increase in transfusion without reducing the incidence of seizure, compared with intravenous tranexamic acid. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03954314.

Anesthesia McMaster University Hamilton ON Canada

Auckland City Hospital New Zealand

Beijing Anzhen Hospital China

Centre de Recherche du Centre Hospitalier de l'Université de Montréal

Centre Intégré Universitaire de Santé et de Services Sociaux du Nord de l'Île de Montréal Hôpital du Sacré Coeur de Montréal QC Canada

Department of Anesthesiology Faculty of Medicine University of Malaya Kuala Lumpur Malaysia

Department of Cardiac Surgery Hospital Agel Trinec Podlesi Trinec Czech Republic

Department of Surgery Case Western Reserve University Cleveland OH

Departments of Health Research Methods Evidence and Impact McMaster University Hamilton ON Canada

Division of Cardiac Surgery University Hospitals Harrington Heart and Vascular Institute Cleveland OH

E Meshalkin National Medical Research Center Novosibirsk Russia

Hamilton Health Sciences Hamilton General Hospital Ontario Canada

Institut Universitaire de Cardiologie et de Pneumologie de Québec Université Laval Québec Canada

Kelowna General Hospital BC Canada

Medicine McMaster University Hamilton ON Canada

Montreal Heart Institute University of Montréal QC Canada

New Brunswick Heart Centre Saint John Canada

Petrovsky National Centre of Surgery Moscow Russia

Population Health Research Institute Hamilton ON Canada

Rujin Hospital Shanghai China

Saint Petersburg State University Hospital Russia

School of Nursing McMaster University Hamilton ON Canada

Shanghai Jiao Tong University School of Medicine China

Surgery McMaster University Hamilton ON Canada

Thrombosis and Atherosclerosis Research Institute McMaster University Hamilton ON Canada

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003834
003      
CZ-PrNML
005      
20250206104729.0
007      
ta
008      
250121s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1161/CIRCULATIONAHA.124.069606 $2 doi
035    __
$a (PubMed)38587333
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Lamy, André $u Population Health Research Institute, Hamilton, ON, Canada (A.L., E.P.B-C., R.P.W., I.C., J.V., R.K., K.B., S.I.B., M.H.M., J.S., S.Y., P.J.D.) $u Surgery (A.L., R.P.W.), McMaster University, Hamilton, ON, Canada $1 https://orcid.org/0000000327777621
245    10
$a Topical Versus Intravenous Tranexamic Acid in Patients Undergoing Cardiac Surgery: The DEPOSITION Randomized Controlled Trial / $c A. Lamy, DA. Sirota, F. Jacques, A. Poostizadeh, N. Noiseux, S. Efremov, P. Demers, B. Akselrod, CY. Wang, RC. Arora, P. Branny, SP. McGuinness, CD. Brown, H. Jeanmart, Q. Zhao, H. Zhang, EP. Belley-Côté, RP. Whitlock, A. Browne, I. Copland, J. Vincent, R. Khatun, K. Balasubramanian, SI. Bangdiwala, MH. McGillion, AE. Fox-Robichaud, J. Spence, S. Yusuf, PJ. Devereaux, DEPOSITION Study Group
520    9_
$a BACKGROUND: Although intravenous tranexamic acid is used in cardiac surgery to reduce bleeding and transfusion, topical tranexamic acid results in lower plasma concentrations compared with intravenous tranexamic acid, which may lower the risk of seizures. We aimed to determine whether topical tranexamic acid reduces the risk of in-hospital seizure without increasing the risk of transfusion among cardiac surgery patients. METHODS: We conducted a multicenter, double dummy, blinded, randomized controlled trial of patients recruited by convenience sampling in academic hospitals undergoing cardiac surgery with cardiopulmonary bypass. Between September 17, 2019, and November 28, 2023, a total of 3242 patients from 16 hospitals in 6 countries were randomly assigned (1:1 ratio) to receive either intravenous tranexamic acid (control) through surgery or topical tranexamic acid (treatment) at the end of surgery. The primary outcome was seizure, and the secondary outcome was red blood cell transfusion. After the last planned interim analysis, when 75% of anticipated participants had completed follow up, the data and safety monitoring board recommended to terminate the trial, and upon unblinding, the operations committee stopped the trial for safety. RESULTS: Among 3242 randomized patients (mean age, 66.0 years; 77.7% male), in-hospital seizure occurred in 4 of 1624 patients (0.2%) in the topical group, and 11 of 1628 patients (0.7%) in the intravenous group (absolute risk difference, -0.5% [95% CI, -0.9 to 0.03]; P=0.07). Red blood cell transfusion occurred in 570 patients (35.1%) in the topical group and in 433 (26.8%) in the intravenous group (absolute risk difference, 8.3% [95% CI, 5.2-11.5]; P=0.007). The absolute risk difference in transfusion of ≥4 units of red blood cells in the topical group compared with the intravenous group was 8.2% (95% CI, 3.4-12.9). CONCLUSIONS: Among patients undergoing cardiac surgery, topical administration of tranexamic acid resulted in an 8.3% absolute increase in transfusion without reducing the incidence of seizure, compared with intravenous tranexamic acid. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03954314.
650    _2
$a lidé $7 D006801
650    12
$a kyselina tranexamová $x aplikace a dávkování $x škodlivé účinky $x terapeutické užití $7 D014148
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    12
$a kardiochirurgické výkony $x škodlivé účinky $7 D006348
650    _2
$a senioři $7 D000368
650    12
$a aplikace lokální $7 D000287
650    12
$a intravenózní podání $7 D061605
650    12
$a antifibrinolytika $x aplikace a dávkování $x škodlivé účinky $x terapeutické užití $7 D000933
650    _2
$a lidé středního věku $7 D008875
650    _2
$a záchvaty $x prevence a kontrola $x etiologie $7 D012640
650    _2
$a dvojitá slepá metoda $7 D004311
650    _2
$a výsledek terapie $7 D016896
650    _2
$a krvácení při operaci $x prevence a kontrola $7 D016063
655    _2
$a časopisecké články $7 D016428
655    _2
$a randomizované kontrolované studie $7 D016449
655    _2
$a multicentrická studie $7 D016448
655    _2
$a srovnávací studie $7 D003160
700    1_
$a Sirota, Dmitry A $u E. Meshalkin National Medical Research Center, Novosibirsk, Russia (D.A.S.)
700    1_
$a Jacques, Frederic $u Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, Canada (F.J.)
700    1_
$a Poostizadeh, Ahmad $u Kelowna General Hospital, BC, Canada (A.P.)
700    1_
$a Noiseux, Nicolas $u Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), QC, Canada (N.N.)
700    1_
$a Efremov, Sergey $u Saint Petersburg State University Hospital, Russia (S.E.) $1 https://orcid.org/0000000155819169
700    1_
$a Demers, Philippe $u Montreal Heart Institute, University of Montréal, QC, Canada (P.D.)
700    1_
$a Akselrod, Boris $u Petrovsky National Centre of Surgery, Moscow, Russia (B.A.)
700    1_
$a Wang, Chew Yin $u Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (C.Y.W.) $1 https://orcid.org/0000000290663830
700    1_
$a Arora, Rakesh C $u Division of Cardiac Surgery, University Hospitals Harrington Heart and Vascular Institute, Cleveland, OH (R.C.A.) $u Department of Surgery, Case Western Reserve University, Cleveland, OH (R.C.A.) $1 https://orcid.org/0000000257993619
700    1_
$a Branny, Piotr $u Department of Cardiac Surgery, Hospital Agel Trinec-Podlesi, Trinec, Czech Republic (P.B.)
700    1_
$a McGuinness, Shay P $u Auckland City Hospital, New Zealand (S.P.M.)
700    1_
$a Brown, Craig D $u New Brunswick Heart Centre, Saint John, Canada (C.D.B.) $1 https://orcid.org/0000000260777263
700    1_
$a Jeanmart, Hugues $u Centre Intégré Universitaire de Santé et de Services Sociaux du Nord-de-l'Île-de-Montréal, Hôpital du Sacré-Coeur de Montréal, QC, Canada (H.J.)
700    1_
$a Zhao, Qiang $u Rujin Hospital, Shanghai, China (Q.Z.) $u Shanghai Jiao Tong University School of Medicine, China (Q.Z.) $1 https://orcid.org/0000000289303854
700    1_
$a Zhang, Haibo $u Beijing Anzhen Hospital, China (H.Z.) $1 https://orcid.org/0000000172493113
700    1_
$a Belley-Côté, Emilie P $u Population Health Research Institute, Hamilton, ON, Canada (A.L., E.P.B-C., R.P.W., I.C., J.V., R.K., K.B., S.I.B., M.H.M., J.S., S.Y., P.J.D.) $u Medicine (E.P.B-C., A.E.F-B., S.Y., P.J.D.), McMaster University, Hamilton, ON, Canada $1 https://orcid.org/000000025071076X
700    1_
$a Whitlock, Richard P $u Population Health Research Institute, Hamilton, ON, Canada (A.L., E.P.B-C., R.P.W., I.C., J.V., R.K., K.B., S.I.B., M.H.M., J.S., S.Y., P.J.D.) $u Surgery (A.L., R.P.W.), McMaster University, Hamilton, ON, Canada $1 https://orcid.org/0000000268635884
700    1_
$a Browne, Austin $u Hamilton Health Sciences, Hamilton General Hospital, Ontario, Canada (A.B.)
700    1_
$a Copland, Ingrid $u Population Health Research Institute, Hamilton, ON, Canada (A.L., E.P.B-C., R.P.W., I.C., J.V., R.K., K.B., S.I.B., M.H.M., J.S., S.Y., P.J.D.)
700    1_
$a Vincent, Jessica $u Population Health Research Institute, Hamilton, ON, Canada (A.L., E.P.B-C., R.P.W., I.C., J.V., R.K., K.B., S.I.B., M.H.M., J.S., S.Y., P.J.D.) $1 https://orcid.org/0000000223568876
700    1_
$a Khatun, Rutaba $u Population Health Research Institute, Hamilton, ON, Canada (A.L., E.P.B-C., R.P.W., I.C., J.V., R.K., K.B., S.I.B., M.H.M., J.S., S.Y., P.J.D.)
700    1_
$a Balasubramanian, Kumar $u Population Health Research Institute, Hamilton, ON, Canada (A.L., E.P.B-C., R.P.W., I.C., J.V., R.K., K.B., S.I.B., M.H.M., J.S., S.Y., P.J.D.)
700    1_
$a Bangdiwala, Shrikant I $u Population Health Research Institute, Hamilton, ON, Canada (A.L., E.P.B-C., R.P.W., I.C., J.V., R.K., K.B., S.I.B., M.H.M., J.S., S.Y., P.J.D.) $u Departments of Health Research Methods, Evidence, and Impact (S.I.B., J.S., P.J.D.), McMaster University, Hamilton, ON, Canada $1 https://orcid.org/0000000231110689
700    1_
$a McGillion, Michael H $u Population Health Research Institute, Hamilton, ON, Canada (A.L., E.P.B-C., R.P.W., I.C., J.V., R.K., K.B., S.I.B., M.H.M., J.S., S.Y., P.J.D.) $u School of Nursing (M.H.M.), McMaster University, Hamilton, ON, Canada
700    1_
$a Fox-Robichaud, Alison E $u Medicine (E.P.B-C., A.E.F-B., S.Y., P.J.D.), McMaster University, Hamilton, ON, Canada $u Thrombosis and Atherosclerosis Research Institute (A.E.F-B.), McMaster University, Hamilton, ON, Canada $1 https://orcid.org/0000000199123606
700    1_
$a Spence, Jessica $u Population Health Research Institute, Hamilton, ON, Canada (A.L., E.P.B-C., R.P.W., I.C., J.V., R.K., K.B., S.I.B., M.H.M., J.S., S.Y., P.J.D.) $u Departments of Health Research Methods, Evidence, and Impact (S.I.B., J.S., P.J.D.), McMaster University, Hamilton, ON, Canada $u Anesthesia (J.S.), McMaster University, Hamilton, ON, Canada
700    1_
$a Yusuf, Salim $u Population Health Research Institute, Hamilton, ON, Canada (A.L., E.P.B-C., R.P.W., I.C., J.V., R.K., K.B., S.I.B., M.H.M., J.S., S.Y., P.J.D.) $u Medicine (E.P.B-C., A.E.F-B., S.Y., P.J.D.), McMaster University, Hamilton, ON, Canada $1 https://orcid.org/0000000347765601 $7 nlk20040153098
700    1_
$a Devereaux, P J $1 https://orcid.org/000000032935637X
710    2_
$a DEPOSITION Study Group
773    0_
$w MED00001091 $t Circulation (New York, N.Y.) $x 1524-4539 $g Roč. 150, č. 17 (2024), s. 1315-1323
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38587333 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104725 $b ABA008
999    __
$a ok $b bmc $g 2263538 $s 1239841
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 150 $c 17 $d 1315-1323 $e 20240408 $i 1524-4539 $m Circulation (New York, N.Y.) $n Circulation $x MED00001091
LZP    __
$a Pubmed-20250121

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...